Shares of Janus Henderson Group plc ( JHG ) traded about 3.5% higher on Monday as the company announced it would be selling itself to Trian, General Catalyst, and a consortium of investors in a dealOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a question for an article, just let me know!Analyst’s Disclosure:I/we have no stock ...

投资服务概览 - 该投资服务专注于全球宏观评论与长线价值投资 旨在寻找国际市场上被错误定价的股票 其投资组合的目标收益率约为4% [1] - 该服务由Valkyrie Trading Society团队运营 该团队分享高确信度且小众的发达市场投资观点 这些观点下行风险有限 并可能在当前经济环境和市场力量下产生非相关性和超常回报 [2] - 该团队为付费会员提供多项服务 包括实时更新的投资组合 24/7问答聊天 定期全球市场新闻报告 对会员股票想法的反馈 每月新交易 季度财报解读以及每日宏观观点 [2] 相关金融产品 - iShares 3-7年期国债ETF是一只中等久期的固定收益ETF 其目标期限的债券在投资组合中不一定容易维持 [2]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Past performance is not an indicator of future performance. This post is illustrative and educational ...

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Past performance is not an indicator of future performance. This post is illustrative and educational ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

Editor's note: Seeking Alpha is proud to welcome Arnav Dash Choudhury as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.I write about companies I find interesting, with the aim of identifying mispricings and overlooked opportunities. My focus is on understanding the underlying business model and how a company makes money, primarily through close reading ...